Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets
May Han(Palo Alto University), Lawrence Steinman(Stanford University), Deborah H. Lundgren(UConn Health), Cedric S. Raine(Albert Einstein College of Medicine), Sun‐Il Hwang(UConn Health), Raymond A. Sobel(Massachusetts General Hospital), Guy Haskin Fernald(University of California, San Francisco), Shalina S. Ousman(Institute of Neurological Sciences), David K. Han(University of Connecticut), Dolly Roy(Northridge Hospital Medical Center), Bruce Gerlitz(Eli Lilly (United States)), Brian W. Grinnell(Eli Lilly (United States)), Sergio E. Baranzini(University of California, San Francisco), Jordan V. Price(Institute of Neurological Sciences), William H. Robinson(Stanford University)
Cited by 519
Related Papers
Multiple sclerosis
|The Lancet|2018|1.8k
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
The MAD-Related Protein Smad7 Associates with the TGFβ Receptor and Functions as an Antagonist of TGFβ Signaling
|Cell|1997|1.3k
Gene Expression Profile of Antithrombotic Protein C Defines New Mechanisms Modulating Inflammation and Apoptosis
|Journal of Biological Chemistry|2001|652